Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Clinical trial NCT04582968 · UNKNOWN

Trial details

NCT number: NCT04582968
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Brain Metastases HER2-positive Breast Cancer

Start date: 2020-01-02
Primary completion: 2022-08-12
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.